IQVIA Holdings Inc.
$277.63
−1.41 · −0.51% today
Market open · updated 12:45:29 PM ET
- High
- $279.36 Oct 23, 2026
- Low
- $157.77 May 1, 2026
Against the S&P 500 Price change through Oct 28, 2026
IQV+23.79%
S&P 500+13.26%
IQV+27.92%
S&P 500+12.41%
IQV+55.07%
S&P 500+88.06%
IQV+8.50%
S&P 500+68.51%
Key numbers
- Previous close
- $279.04
- Open
- $276.86
- Day's range
- $274.39 – $279.36
- 52-week range
- $154.50 – $284.50
- Volume
- 467,195
- Average volume
- 1.4 million
- Market value
- $45.7 billion
- Price to earnings
- 33.5last 12 months
- Earnings per share
- $8.46last 12 months
- Beta
- 1.17moves about 1.2× as much as the market
- Dividend
- None
- 50-day average
- $265.35
- 200-day average
- $209.22
Analyst price targets and the full financials are in the terminal.
Who IQVIA sells to and competes with From our value chain
IQVIA in the news
- HeadlineWhat IQVIA (IQV) Said on Its Q3 Earnings CallMarketBeat · October 27, 2026 at 4:04 PM ET
- HeadlineIQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/YZacks Investment Research · October 27, 2026 at 11:46 AM ET
- HeadlineIQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue EstimatesZacks Investment Research · October 27, 2026 at 9:16 AM ET
- Pre-market reportPre-Market Report, Oct 27: Futures Rise, Durable Goods Due, Fed Meeting StartsWiseView Research desk · October 27, 2026
- HeadlineIQVIA Reports Third-Quarter 2026 ResultsGuruFocus · October 27, 2026 at 8:00 AM ET
- HeadlineIQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should KnowZacks Investment Research · October 22, 2026 at 11:02 AM ET
- HeadlineIQVIA: R&D Bookings Are Reaccelerating, But The Valuation Now Requires ExecutionSeeking Alpha · October 20, 2026 at 11:21 AM ET
- HeadlineIQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?Zacks Investment Research · October 20, 2026 at 11:00 AM ET
Congress trades in IQV
2 purchases and 6 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Kevin HernHouse · R-Oklahoma | Sale | $15,001 - $50,000 | Sep 14, 2026 | Sep 28, 2026 |
| Kevin HernHouse · R-Oklahoma | Sale | $1,001 - $15,000 | Sep 8, 2026 | Sep 28, 2026 |
| Kevin HernHouse · R-Oklahoma | Sale | $1,001 - $15,000 | Sep 3, 2026 | Sep 28, 2026 |
| Kevin HernHouse · R-Oklahoma | Sale | $50,001 - $100,000 | Mar 16, 2026 | Apr 6, 2026 |
| Markwayne MullinSenate | Purchase | $15,001 - $50,000 | Dec 29, 2025 | Jan 16, 2026 |
| John BoozmanSenate | Sale | $1,001 - $15,000 | Oct 2, 2025 | Nov 15, 2025 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 29, 2025 | Oct 3, 2025 |
| Rob BresnahanHouse | Sale | $1,001 - $15,000 | May 15, 2025 | Jun 2, 2025 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About IQVIA
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 93,000
- Headquarters
- Durham, North Carolina
- Website
- iqvia.com
- Listed
- May 9, 2013
More medical - diagnostics & research stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.